newsfilter
← Latest News
GlobeNewswire·

Heron Therapeutics Announces First Quarter 2026 Financial Results and Reaffirms Guidance

Q1 2026 net revenue growth year-over year for Acute Care franchise (+32%), including ZYNRELEF® (+27%) and APONVIE® (+50%)Q1 2026 total net revenue of $34.7 millionReached settlement with Baxter Healthcare